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The CED-4 homo-oligomer or apoptosome is re-
quired for initiation of programmed cell death in
Caenorhabditis elegans by facilitating autocatalytic
activation of the CED-3 caspase zymogen. How the
CED-4 apoptosome assembles and activates CED-
3 remains enigmatic. Here we report the crystal
structure of the complete CED-4 apoptosome and
show that it consists of eight CED-4molecules, orga-
nized as a tetramer of an asymmetric dimer via a
previously unreported interface among AAA+
ATPases. These eight CED-4 molecules form a fun-
nel-shaped structure. The mature CED-3 protease
is monomeric in solution and forms an active holoen-
zyme with the CED-4 apoptosome, within which the
protease activity of CED-3 is markedly stimulated.
Unexpectedly, the octameric CED-4 apoptosome
appears to bind only two, not eight, molecules of
mature CED-3. The structure of the CED-4 apopto-
some reveals shared principles for the NB-ARC
family of AAA+ ATPases and suggests a mechanism
for the activation of CED-3.
INTRODUCTION
Programmed cell death (PCD), also known as apoptosis, is
essential to metazoan development and tissue homeostasis
(Danial and Korsmeyer, 2004; Horvitz, 2003). The biochemical
pathway for the initiation of apoptosis is conserved across
species, culminating in the activation of cell-killing proteases
known as caspases (Yan and Shi, 2005). In Caenorhabditis
elegans (C. elegans), PCD is carried out by the CED-3 caspase.446 Cell 141, 446–457, April 30, 2010 ª2010 Elsevier Inc.Similar to all known caspases, CED-3 is synthesized as an inac-
tive zymogen in cells and its maturation involves autocatalytic
cleavages. Autoactivation of CED-3 strictly depends on the
adaptor protein CED-4. In response to cell death stimuli, CED-
4 is released from an inactive complex containing an asymmetric
homodimer of CED-4 and one molecule of the anti-death protein
CED-9 (Yan et al., 2004, 2005). The freed CED-4 protein further
oligomerizes to assemble into a higher-order homo-oligomer,
hereafter referred to as the CED-4 apoptosome, which recruits
CED-3 zymogen and facilitates its autocatalytic activation (Yan
et al., 2006b; Yang et al., 1998a). Preliminary analysis by electron
microscopy (EM) revealed that the CED-4 apoptosome exhibited
a four-fold symmetry, which was thought to correspond to a
tetramer (Yan et al., 2005).
Themammalian protein Apaf-1 is a CED-4 homolog (Zou et al.,
1997). Under homeostatic conditions, Apaf-1 exists in an autoin-
hibited state (Li et al., 1997; Riedl et al., 2005). In response to
apoptotic stimuli, Apaf-1 binds to cytochrome c and undergoes
a nucleotide exchange process, which drives the formation of
an oligomeric apoptosome (Bao et al., 2007; Kim et al., 2005;
Li et al., 1997). The Apaf-1 apoptosome recruits caspase-9, a
CED-3 homolog, and mediates its autocatalytic activation. In
the absence of Apaf-1, caspase-9 can be activated through
forced dimerization (Chao et al., 2005; Renatus et al., 2001; Yin
et al., 2006). However, how exactly the Apaf-1 apoptosome acti-
vates caspase-9 remains enigmatic (Shi, 2004), and a conclusive
answer to this question may require detailed structural informa-
tion of the Apaf-1 apoptosome bound to caspase-9. EM analysis
revealed that the Apaf-1 apoptosome existed mainly as a disc-
shaped homo-heptamer (Acehan et al., 2002; Yu et al., 2005).
The fruit fly homolog of Apaf-1 was identified as Dark (Rodriguez
et al., 1999), Hac-1, or Dapaf-1 (Kanuka et al., 1999; Zhou et al.,
1999). Dark, known to form an octameric apoptosome (Yu et al.,
2006), is responsible for the activation of the caspase Dronc, a
homolog of CED-3 and caspase-9.
Assembly of apoptosomes is a central event in apoptosis (Bao
and Shi, 2007). At present, structural information on the apopto-
some is exclusively derived from EM-based investigation and
computational modeling (Acehan et al., 2002; Diemand and
Lupas, 2006; Yu et al., 2005, 2006). Due to low resolution of
the EM studies and the hypothetical nature of modeling, the
essential features of apoptosomes are yet to be elucidated.
Consequently, mechanistic understanding on apoptosome
assembly and function has been slow to emerge.
CED-4, Apaf-1, and Dark share a number of unique sequence
features, including a caspase recruitment domain (CARD) at their
N termini, followed by a nucleotide-binding a/b-fold, a small
helical domain (helical domain 1, or HD1), a winged-helix domain
(WHD), and helical domain 2 (HD2). These sequence features are
similar to several other families of signaling proteins, such as the
pathogen resistance proteins (R proteins) in plants (Belkhadir
et al., 2004; Takken et al., 2006; van Ooijen et al., 2008). The R
proteins are activated in response to pathogen invasion and
trigger-localized PCD (known as hypersensitive response)
(Martin et al., 2003). Collectively, these signaling proteins define
a unique family known as NB-ARC (nucleotide-binding, Apaf-1,
R proteins, and CED-4) (van der Biezen and Jones, 1998), which
belong to the AAA+ superfamily of ATPases (Lupas and Martin,
2002). The active form of the NB-ARC proteins is thought to be
oligomeric. Despite vigorous efforts, there is no detailed struc-
tural information on any of the oligomeric NB-ARC proteins.
Understanding the structure and function of the apoptosome
may shed light on the NB-ARCs, particularly on the R proteins.
In this manuscript, we report the structure of the complete
CED-4 apoptosome, revealing insights into apoptosome
assembly that may be applicable to other apoptosomes. To
elucidate the mechanisms of assembly and those involved in
the activation of CED-3, we performed structure-guided bio-
chemical analysis. The conclusions derived from this study
may be helpful for mechanistic understanding of other NB-ARC
proteins.
RESULTS
Overall Structure of the CED-4 Apoptosome
Using a published protocol (Yan et al., 2005), we generated a
homogeneous CED-4 apoptosome and obtained several crystal
forms. Unfortunately none of these crystals diffracted X-rays
beyond 10 A˚ resolution, likely due to crystal packing imperfec-
tion caused by flexible surface loops. To remedy this problem,
we subjected the CED-4 apoptosome to limited proteolysis,
which removed a surface loop comprising residues 498–517
(Figure S1A available online). The resulting CED-4 apoptosome
retained the same ability to facilitate autocatalytic activation of
CED-3 as the undigested CED-4 (Figure S1B). We succeeded
in the generation of diffraction-quality crystals for the proteo-
lysed CED-4 apoptosome and determined its X-ray structure
at 3.55 A˚ resolution (Table S1). Each asymmetric unit contains
an asymmetric dimer of CED-4, and the CED-4 apoptosome is
formed via a crystallographic four-fold symmetry.
The CED-4 apoptosome has a funnel-shaped architecture,
with a height of 110 A˚ and a diameter of 170 A˚ (Figure 1,
Figures S1C and S1D). The assembly contains eight moleculesof CED-4, arranged as a tetramer of an asymmetric dimer.
Each CED-4 contains an ATP molecule and a Mg2+ ion, both
buried in the assembly and inaccessible to water molecules
(Figure 1A, Figure S1E). The eight CARDs form two staggered,
tetrameric rings at the narrow end of the funnel-shaped complex,
giving rise to an overall four-fold symmetry (Figure 1A). Four
CARDs, one from each asymmetric CED-4 dimer, associate
with each other to assemble into a closed, tetrameric ring;
whereas the other four CARDs are interspersed by CARDs of
the closed ring. In our previous EM-based study, this four-fold
symmetry was thought to come from four molecules of CED-4
(Yan et al., 2005); however, fitting four molecules of CED-4 into
the EM density still left a substantial portion of the electron
density unoccupied. This conundrum is nicely resolved by
revelation of the present crystal structure—the basic unit of the
CED-4 apoptosome is an asymmetric dimer, rather than a single
molecule, of CED-4.
The CED-4 apoptosome contains a cone-shaped, interior
space that measures 50 A˚ in height and 36–90 A˚ in diameters
(Figure 1B). This space, hereafter referred to as the ‘‘hutch,’’ is
large enough to accommodate a folded, globular protein with
molecular weight of 60–80 kDa. The hutch is connected to an
axial channel, which traverses the center of the CED-4 apopto-
some and measures 60 A˚ in length and 16–36 A˚ in diameters.
The interior surface of the CED-4 apoptosome is enriched by
positively charged amino acids, whereas the exterior exhibits a
mixture of acidic and basic electrostatic potential (Figure S1D).
In each CED-4 molecule, the five sequential domains, CARD,
a/b-fold, HD1, WHD, and HD2, are arranged approximately
in a linear fashion from the narrow end to the wide end of the
funnel-shaped complex (Figure 1B). The primary oligomerization
interface is mediated by the a/b-fold, HD1, and WHD domains.
TheCARDs, especially the four at the narrow end of the complex,
have high temperature factors, suggesting certain degrees of
flexibility (Figure 1C).
Organization of the Three-Layer Ring Structure
The funnel-shaped CED-4 apoptosome is organized into three
layers of ring structure (Figure 2). The top, middle, and bottom
layers are formed by the CARDs, the a/b-fold and HD1, and
the HD1 and WHD, respectively. The top layer consists of eight
CARDs, which are arranged in two contrasting orientations
(Figure 2A). Four CARDs form a symmetric tetramer, capping
the narrow end of the funnel (Figure 2A, colored green). These
four CARDs make no direct interactions with the a/b-fold or the
HD1; rather, they interdigitate with four additional CARDs that
directly interact with the middle layer. The two different CARD
positions relative to the rest of the CED-4molecules arematched
by the different conformations of a 13 residue linker sequence
(residues 98–110), which connect the CARD to the a/b-fold
(Figure S1F). Together, these eight CARDs form a staggered
ring with four-fold symmetry.
In the middle layer, eight a/b domains stack against one
another to form a closed ring, with the HD1 domains radiating
outwards andmaking few interactionswith adjacent a/bdomains
(Figure 2B). In the bottom layer, eight HD1 domains alternate
with eight WHD domains to form a large ring structure (Fig-
ure 2C). Together, the middle and the bottom layers areCell 141, 446–457, April 30, 2010 ª2010 Elsevier Inc. 447
Figure 1. Structure of the CED-4 Apoptosome
(A) Overall structure of the CED-4 apoptosome in three perpendicular views. The CED-4 apoptosome is a tetramer of the asymmetric CED-4 homodimer, with the
two CED-4 molecules colored green and magenta. Each CED-4 contains a deeply buried ATP molecule and a Mg2+ ion.
(B) A section of the CED-4 apoptosome through the central axis. This representation highlights the hutch—the cone-shaped space within the apoptosome.
(C) The CARDs have high temperature factors. All structural figures were prepared using PyMol (DeLano, 2002).
See also Figure S1.intertwined, involving a buried surface area of approximately
23188 A˚2 for eight CED-4molecules, and constitute the predom-
inant determinant of CED-4 oligomerization. Although the top
layer has a four-fold symmetry (Figure 2A), the middle and
bottom layers display an approximate eight-fold symmetry
(Figures 2B and 2C), where the intermolecular interface within
the same CED-4 asymmetric dimer is nearly identical to that
between two CED-4 asymmetric dimers.
The interface organization of the CED-4 apoptosome is
different from that of all other known AAA+ proteins (Neuwald
et al., 1999), which share a generally conserved domain organi-
zation at the oligomeric interface (Diemand and Lupas, 2006).
In other AAA+ proteins exemplified by the hexameric NSF
(N-Ethylmaleimide sensitive factor) (Lenzen et al., 1998; Yu
et al., 1998) and heptameric NtrC1 (Lee et al., 2003), the a/b-fold
of one molecule interacts predominantly with the HD1 of the
adjacent molecule, and both the a/b-fold and the HD1 domains
are located approximately within the plane of the ring structure448 Cell 141, 446–457, April 30, 2010 ª2010 Elsevier Inc.(Figure S2). By contrast, the a/b-fold of one CED-4 molecule
makes only a few interactions with the HD1 of the adjacent mole-
cule, and the HD1 domain is tilted out of the plane of the ring
structure toward the wide end of the funnel-shaped CED-4
apoptosome (Figure S2). This domain organization leaves ample
space between two adjacent HD1 domains, where WHD binds.
Sequence conservation among NB-ARC proteins suggests
that this previously unreported oligomerization interface may
be conserved in the Apaf-1 apoptosome, the Dark apoptosome,
and perhaps the R proteins.
Interface between Adjacent CED-4 Molecules
The eight CED-4 molecules in the apoptosome display two
different interfaces between adjacent CED-4 molecules (Fig-
ure 3A). To facilitate presentation, the CED-4 molecule with
CARD located at the narrow end of the apoptosome is referred
to as CED-4b; the other CED-4 is termed CED-4a. The only
marked conformational difference between CED-4a and CED-4b
Figure 2. The CED-4 Apoptosome Consists of Three Layers of
Stacked Ring Structures
(A) The CARD ring resides at the narrow end of the funnel-shaped CED-4
apoptosome.
(B) The middle ring structure is formed by eight a/b domains (colored green
and magenta). The HD1 domains radiate outward and make few interactions
with adjacent a/b domains.
(C) The bottom ring structure contains 16 domains, with 8 HD1 domains alter-
nating with 8 WHD domains. The HD1 are colored cyan in all eight subunits,
whereas other domains are colored green and magenta to correspond to
the two molecules in each asymmetric dimer.
See also Figure S2.is the location of the CARD relative to the other domainswithin the
samemolecule (Figure 3B). In CED-4b, the CARDmainly interacts
with two surrounding CARDs from adjacent CED-4a molecules
(Figures 3A and 3C). In CED-4a, however, the CARD interacts
with four domains: the a/b-fold within the sameCED-4amolecule,
ana/b-fold fromone adjacentCED-4bmolecule, andbothCARDs
from the surrounding CED-4b molecules (Figures 3A and 3C).
Interestingly, the CARD from CED-4a maintains the same confor-
mation as that observed in CED-4a from the (CED-4)2:CED-9
complex (Yan et al., 2005). Given the high temperature factors of
the CARDs (Figure 1C), we cannot rule out the possibility that
the observed conformation of the CARDs in CED-4b and, to a
lesser extent, CED-4a may be influenced by crystal packing.
The principal determinant for formation of the CED-4 apopto-
some is the shared interface within the asymmetric CED-4 dimer
and between two adjacent CED-4 dimers. This interface involves
an extensive buried surface area of 3775 A˚2 (Figure S3). At this
interface, the a/b-fold not only stacks against the HD1 and theWHD within the same CED-4 molecule but also interacts with
the a/b-fold of the adjacent CED-4 molecule.
InC. elegans, formation of the CED-4 apoptosome is triggered
by EGL-1-mediated release of the asymmetric CED-4 dimer
from the (CED-4)2:CED-9 complex (Yan et al., 2005). Superposi-
tion of the (CED-4)2:CED-9 complex into the CED-4 apoptosome
revealed that the structure of the asymmetric CED-4 dimer from
the (CED-4)2:CED-9 complex is nearly identical to that in the
CED-4 apoptosome except for the CARD of CED-4b, which
was disordered in the (CED-4)2:CED-9 complex (Figure 3D).
Another appreciable difference is the conformation of a loop
sequence between helices a11 and a12 in the a/b-fold. The
superposition also illustrates that CED-9 from the (CED-4)2:
CED-9 complex overlaps with an adjacent CED-4 molecule in
the CED-4 apoptosome, explaining why CED-9 must be dis-
placed in order for the CED-4 apoptosome to assemble.
Implication for the Apaf-1 Apoptosome
Apaf-1 shares approximately 45% sequence similarity with
CED-4 in their N-terminal 500 amino acids (Zou et al., 1997)
(Figure S4A). Although CED-4 and the autoinhibited Apaf-1
exhibit different overall conformations, the individual domains
of CED-4—CARD, a/b-fold, HD1, and WHD—can be superim-
posed very well with the corresponding domains of Apaf-1
(Figure 4A). For example, the a/b-fold and HD1 domains can
be superimposed with a root-mean-square deviation (rmsd) of
1.6 A˚ for 156 aligned Ca atoms between these two proteins.
This analysis suggests that the activated Apaf-1 may have
a conformation similar to that of CED-4. A model of the activated
Apaf-1 monomer was constructed by placing the CARD, WHD,
and HD2 domains into the corresponding positions of CED-4
(Figure 4B).
Next, we generated an atomic model of the Apaf-1 apopto-
some using the modeled structure of the activated Apaf-1
(Figure 4C). The seven-fold symmetry was generated by rotating
each Apaf-1 molecule by 51.4 (360/7) degrees along a central
axis. There is little steric clash among the backbone atoms of
the seven Apaf-1 molecules, and the HD2 domains radiate
outwards, consistent with the observed features of the electron
density map derived from EM studies (Acehan et al., 2002; Yu
et al., 2005).
We sought to experimentally corroborate the model of the
Apaf-1 apoptosome. In the CED-4 apoptosome, Leu209 on
a11 and Leu217/Leu218 in the loop of oneCED-4molecule stack
against Val230, Arg233, and Met234 on a12 of an adjacent
CED-4 molecule (Figure S4B). Based on the model of the
Apaf-1 apoptosome, this part of the intersubunit interface is
likely mediated by Asn201/Thr204/Arg205 on a11, Gln208/
Arg215 in the intervening loop, and Glu221/Asp225/Arg226 on
a12 (Figure S4B). We generated and purified two mutant Apaf-
1DC proteins (residues 1–591), N201A/T204R/R205E/Q208A
(named mut1) and R215D/E221R/D225R/R226D (mut2), and
examined their ability to form a miniapoptosome. Although the
wild-type (WT) Apaf-1DC formed a stable miniapoptosome in
the presence of dATP (Riedl et al., 2005), both mutants failed
to do so (Figure 4D). To pinpoint the functionally important amino
acids, we generated and purified six mutant Apaf-1DC proteins,
each with a single missense mutation. Although T204R andCell 141, 446–457, April 30, 2010 ª2010 Elsevier Inc. 449
Figure 3. Asymmetry in the CED-4 Apopto-
some
(A) The interface from CED-4a to CED-4b is nearly
identical to that from CED-4b to CED-4a except
for the CARD-CARD interactions. CED-4 is shown
in a surface, mesh representation.
(B) A stereo comparison between CED-4a and
CED-4b. The only major difference between these
two CED-4 molecules is the relative positions of
the CARDs.
(C) A close-up view of the CARD-CARD packing
interactions.
(D) Superposition of the (CED-4)2:CED-9 complex
onto the CED-4 apoptosome revealed serious
overlap between CED-9 and adjacent CED-4
subunits. This analysis explains why CED-9 must
be removed for the CED-4 dimer to oligomerize.
See also Figure S3.Q208A behaved similarly to the WT protein, four Apaf-1DC
mutants—N201A, E221R, D225R, and R226D—crippled the
ability to form a miniapoptosome (Figure 4E).
Our structure-based model differs from the published model
of the Apaf-1 apoptosome (Figure 4F). There are three major
differences. First, in our model, the a/b-fold of one Apaf-1 mole-450 Cell 141, 446–457, April 30, 2010 ª2010 Elsevier Inc.cule directly interacts with the a/b-folds of neighboring Apaf-1
molecules. In the published model (Acehan et al., 2002; Yu
et al., 2005), however, there is no direct contact between these
domains. Second, in our model, the CARDs are positioned
above the main ring structure, away from the central axis, and
do not make major contributions to apoptosome formationFigure 4. Assembly of the Apaf-1 Apopto-
some
(A) Individual domains of CED-4 and Apaf-1 are
structurally conserved. This comparison gives
rise to the basis for where interdomain movement
should occur in Apaf-1 in response to ATP/dATP
binding.
(B) Superposition of CED-4 (magenta) and the
modeled, activated Apaf-1 (cyan).
(C) An atomic model of the Apaf-1 apoptosome on
the basis of the CED-4 apoptosome. Note that the
CARDs do not make a major contribution to ring
formation in this model.
(D) Mutation of residues at the predicted interface
of the Apaf-1 apoptosome resulted in abrogation
of apoptosome formation. Shown here are chro-
matograms of gel filtration. Two mutants of
Apaf-1DC, one containing N201A/T204R/R205E/
Q208A (mut1) and the other R215D/E221R/
D225R/R226D (mut2), both led to loss of apopto-
some assembly.
(E) Identification of individual amino acids that
contribute to the formation of the Apaf-1 apopto-
some. Six mutant Apaf-1DC proteins, each with
a single missense mutation, were generated and
evaluated for their ability to form a miniapopto-
some.
(F) Our structure-basedmodel of the Apaf-1 apop-
tosome differs from the published model (Acehan
et al., 2002; Yu et al., 2005).
See also Figure S4.
Figure 5. CED-4 and Processed CED-3
Form a Stable Holoenzyme
(A) The processedCED-3 exhibited higher levels of
protease activity in the presence of CED-4. Shown
here is a representative result of four independent
experiments.
(B) The protease activity of processed CED-3 was
stimulated by CED-4 in a concentration-depen-
dent manner. Shown here is a representative
result of three independent experiments.
(C) CED-4 stimulated the protease activity of the
two-chain CED-3 (residues 198–374, 389–503,
D221A). The error bars represent standard devia-
tions of ten independent experiments.
(D) The CED-4 apoptosome formed a stable
complex with the two-chain CED-3 (residues
198–374, 389–503, C358A). Shown on the left
are representative gel-filtration chromatograms
of CED-4 alone, CED-3, and CED-4 incubated
with excess CED-3. The peak fractions were visu-
alized on SDS-PAGE.
(E) The CED-4 apoptosome also formed a stable
complex with the CED-3 zymogen (residues
198–503, C358A). The peak fraction of the
CED-4:CED-3 complex from gel filtration was
subjected to capillary electrophoresis under dena-
turing conditions. Shown here is a representative
result of five independent experiments. This anal-
ysis yielded a calculated molar ratio of 3.8 ± 0.2
for CED-4 over CED-3. The error bar represents
standard error of the mean.
(F) Quantitative analysis of the CED-4:CED-3 inter-
actions confirmed the 4:1 molar ratio. Binding of
uncleaved CED-3 (residues 198–503, C358A) or
two-chain CED-3 (residues 198–374, 389–503,
C358A) by CED-4 was examined by isothermal
titration calorimetry (ITC).
See also Figure S5.(Figure 4C). By contrast, the published model placed the CARDs
in a closed ring structure around the central axis, which appears
to contribute to apoptosome formation (Figure 4F). Third, the
WHD domains are thought to bridge adjacent HD1 domains in
our model, whereas they were proposed to link adjacent, nonin-
teracting a/b domains in the EM-based model. A modeling
study suggested that the published model of the Apaf-1 apopto-
some may conflict with a number of structural considerations
(Diemand and Lupas, 2006).
CED-4 Markedly Stimulates the Protease Activity
of Processed CED-3
The CED-4 apoptosome facilitates the autocatalytic processing
of the CED-3 zymogen (Seshagiri and Miller, 1997; Yan et al.,
2005; Yang et al., 1998b). It is unclear, however, whetherCell 141, 446–4CED-4 can also stimulate the protease
activity of the processed CED-3. To
examine this scenario, we attempted to
express and purify recombinant CED-3
protein. We expressed theWT, full-length
CED-3 and a number of mutant CED-3
proteins in E. coli, Saccharomyces cere-visiae, or baculovirus-infected insect cells. Despite overexpres-
sion, the full-length CED-3 proteins were insoluble. We were
able to solubilize the full-length CED-3 by in vitro refolding;
however, the refolded CED-3 protein was prone to aggregation
and unfit for biochemical characterization. After testing dozens
of constructs, we found a 34 kDa CED-3 fragment (residues
198–503) that exhibited good solution behavior, allowing enzy-
matic and biophysical investigation. Expression of this CED-3
fragment in E. coli gave rise to fully processed, active CED-3
protease (Figure S5A); whereas mutation of the catalytic residue
Cys358 to Ser allowed purification of this fragment to homoge-
neity (Figure S5B).
We investigated the impact of CED-4 on the protease activity
of the processed, active CED-3 using the fluorogenic substrate
DEVD-AMC (Figure 5A). The processed CED-3 exhibited a basal57, April 30, 2010 ª2010 Elsevier Inc. 451
level of protease activity. Incubation of CED-3 with the full-
length, WT CED-4 led to a markedly enhanced level of protease
activity. This effect is specific to CED-4, as incubation with BSA
failed to enhance the protease activity. Importantly, the increase
of the CED-3 protease activity is correlated with increasing
concentrations of CED-4, suggesting saturable interactions
between CED-4 and the processed CED-3 protease (Figure 5B).
In these experiments, the processed, active CED-3 proteasewas
derived from the 34 kDa CED-3 fragment (residues 198–503),
which was autocatalytically processed during overexpression
in E. coli. Similar results were obtained for a two-chain CED-3
protease (residues 198–374 and 389–503) (Figure 5C), which
was generated by coexpression of the two chains in E. coli.
These observations demonstrate that, under the experimental
conditions tested, the CED-4 apoptosome stimulated the
protease activity of the mature CED-3 protease by 5- to 10-fold.
Formation of a CED-3-CED-4 Holoenzyme
Stimulation of CED-3 activity by CED-4 suggests that the pro-
cessed CED-3 protease may form a stable complex with the
CED-4 apoptosome. We generated a two-chain CED-3 variant
(residues 198–374 and 389–503, C358S) and examined its
potential interaction with CED-4 using gel filtration. Mutation of
the catalytic residue Cys358 to Ser was essential to allow
accumulation of sufficient CED-3 protein for biochemical char-
acterization. The elution volume for the two-chain CED-3 alone
from gel filtration corresponded to a molecular mass of35 kDa
(Figure 5D), consistent with that of a monomer. Upon incubation
with CED-4, a portion of the two-chain CED-3 was shifted to
earlier fractions and was coeluted with the CED-4 apoptosome.
These observations indicate that the two-chain CED-3 (C358S)
formed a stable complex with the CED-4 apoptosome. Curi-
ously, however, the molar ratio between CED-4 and CED-3, as
suggested by the intensity of Coomassie blue staining (Fig-
ure 5D), did not appear to be 1:1. Similar to the two-chain
CED-3, the unprocessed, single-chain CED-3 (residues 198–
503, C358S) also formed a stable complex with the CED-4
apoptosome (Figure 5E). In both cases, the molar quantity of
CED-3 seemed to be substantially less than that of CED-4.
To determine the molar ratio between CED-4 and CED-3, we
applied the preassembled, stoichiometric CED-4-CED-3 com-
plex to capillary electrophoresis under denaturing conditions,
which separated CED-3 from CED-4 (Figure 5E). The proteins
were detected by UV absorbance at 280 nm, and the total UV
absorbance for CED-3 and CED-4 was integrated. The total
molar quantities of CED-3 and CED-4 were derived by dividing
their total UV absorbance by their respective molar extinction
coefficients at 280 nm. This analysis, representing five indepen-
dent experiments, yielded a calculatedmolar ratio of 3.8 ± 0.2 for
CED-4 over CED-3. Consistent with this analysis, quantification
of gel-filtration experiments yielded a molar ratio of approxi-
mately 4:1 between CED-4 and CED-3. These observations
suggest that the octameric CED-4 complex may associate with
only two, rather than eight, molecules of CED-3.
To further characterize the interactions, we determined the
binding affinity between CED-3 and CED-4 using isothermal
titration calorimetry (ITC). The concentrations of CED-4 octamer
and CED-3 dimer were used to fit the binding curves (Figure 5F).452 Cell 141, 446–457, April 30, 2010 ª2010 Elsevier Inc.The CED-4 apoptosome bound to the uncleaved CED-3 (resi-
dues 198–503, C358S) and the two-chain CED-3 (residues
198–374, 389–503, C358S) with dissociation constants of
approximately 1.73 ± 0.44 mM and 1.25 ± 0.26 mM, respectively.
In both cases, the molar ratio between the CED-4 octamer and
the CED-3 dimer was fitted to be approximately 1.0, confirming
the notion that the CED-4 apoptosome may only associate with
two molecules of CED-3.
Model of the CED-4:CED3 Complex
For all known caspases, the active form is a homodimer because
formation of the active site in one protomer requires the L20 loop
from the adjacent protomer through loop-bundle interactions
(Shi, 2002). We suspected that the CED-4 apoptosome may
help assemble a CED-3 homodimer, thus stimulating its pro-
tease activity. In this case, free CED-3 was speculated to exist
as a monomer in solution. Supporting this notion, both the un-
cleaved CED-3 fragment (residues 198–503, C358S) and the
two-chain CED-3 (residues 198–374, 389–503, C358S) were
eluted from gel filtration with an apparent molecular mass of
35 kDa, consistent with that of a monomer (Figure S5C). This
observation suggests that the intrasubunit cleavage failed to
induce dimerization of CED-3. This result is reminiscent of
the mammalian initiator caspase-9 (Shiozaki et al., 2003) and
contrasts the scenario for caspase-8 (Boatright et al., 2003;
Donepudi et al., 2003) or the Drosophila initiator caspase Dronc
(Yan et al., 2006a). Supporting this finding, sedimentation equi-
librium analysis of the two-chain CED-3 revealed a molecular
weight of 35.25 kDa (Figure S5D), similar to the calculated
molecular weight of 34.29 kDa for the monomeric CED-3 (resi-
dues 198–503, C358S).
Our experimental observations suggest a scenario in which
the octameric CED-4 apoptosome associates with two mono-
mers of CED-3 and mediates their activation. To gain insights
into this process, we crystallized a stable complex between
the CED-4 apoptosome and the two-chain CED-3 or the un-
cleaved CED-3 (residues 198–503, C358S) in the space group
I422. Analysis of the crystals by SDS-PAGE revealed the pres-
ence of both CED-4 and CED-3, with the intensities of Coomas-
sie staining consistent with the 8:2 molar ratio between CED-4
and CED-3 (Figure 6A, inset; Figure S6A). The structure was
refined at 3.9 A˚ resolution (Table S2). Despite the presence of
CED-3 in the crystals, there was no discernable electron density
for CED-3. This unanticipated outcome can be explained by
CED-4 packing in the crystals. Each asymmetric unit contains
two protomers of CED-4, and the octameric CED-4 complex is
formed via a four-fold crystallographic symmetry operation.
Examination of the crystal lattice indicated that there are only
two potential locations that are large enough to accommodate
two protomers of CED-3. One is outside the CED-4 octamer,
between four pairs of CED-4 protomer, with each pair coming
from a distinct CED-4 apoptosome (Figure S6B). This arrange-
ment would give rise to a molar ratio of 1:1 between CED-4
and CED-3, inconsistent with experimental observations. The
only other location is the hutch of the funnel-shaped CED-4
octamer (Figure 5A). In this case, the electron density for CED-3
may be averaged to noise level due to at least four potential
binding orientations in the hutch.
Figure 6. The CED-4 ApoptosomeMay Bind
to the Processed CED-3 within the Hutch
(A) Structure of the CED-4:CED-3 complex.
Despite presence of the CED-3 protein in the crys-
tals, there was no apparent electron density for it.
The hutch of the CED-4 apoptosome in the crystal
is large enough to accommodate the CED-3
dimer. This scenario also provides a plausible
explanation as to why there was no electron
density for CED-3, as the four-fold crystallo-
graphic symmetry operator likely decimated the
electron density for CED-3 that could bind in
multiple orientations within the hutch of the
CED-4 octamer.
(B) Cryo-EM analysis of the complex between
CED-4 and two-chain CED-3. Examination of the
averaged cryo-EM images of the complex
between CED-4 and two-chain CED-3 revealed
some electron density in the center of the CED-4
apoptosome. This density, indicative of CED-3,
is absent in the averaged cryo-EM images of
the CED-4 apoptosome alone. Shown here are
the side views of the CED-4 particle and the
CED-4:CED-3 complex.
(C) A model of the CED-4 apoptosome bound to
the catalytic core domain of CED-3 dimer.
See also Figure S6.Although themultiple, contrasting orientations of CED-3 within
the CED-4 apoptosome pose a problem for X-ray diffraction,
they are amenable to cryo-EM analysis. In agreement with the
above analysis, cryo-EM investigation of the CED-4:CED-3
complex revealed extra electron density within the CED-4 apop-
tosome (Figure 6B). The size and location of these extra densities
are consistent with those predicted for CED-3. In addition, the
size of the CED-4 particles is consistent with the crystal structure
of the CED-4 apoptosome. Importantly, these extra electron
densities are absent in the averaged images of the CED-4 apop-
tosome alone. These observations suggest that two molecules
of CED-3 may be accommodated in the hutch (Figure 6C).
DISCUSSION
The CED-4 Apoptosome Is a Tetramer of Dimers
Our previous EM study suggested a four-fold symmetry within
the CED-4 apoptosome, which was interpreted as a tetramer
of the CED-4 molecule (Yan et al., 2005). However, fitting four
molecules of CED-4 into the EM density invariably left a substan-
tial portion of the density unaccounted for. In addition, our
biochemical data strongly suggested that the interface in the
CED-4 apoptosome is very similar to that between two mole-
cules within the same asymmetric CED-4 dimer (Yan et al.,
2005). If the interface between the asymmetric CED-4 dimer
were to be propagated, the resulting, closed CED-4 ring would
involve eight, not four, molecules. Our current structure provides
a satisfactory solution to these problems. Due to the contrasting
CARD conformations, the CED-4 apoptosome exhibits a perfect
four-fold symmetry, consistent with previous EM observations(Yan et al., 2005). However, the basic structural unit is an asym-
metric dimer of CED-4, not a monomer. The eight molecules of
CED-4 nicely occupy the electron density in the EM-based
map of the CED-4 apoptosome.
Activation of the NB-ARC Proteins
The R proteins constitute a central component of the plant
immune system (Belkhadir et al., 2004; Takken et al., 2006). In
response to a pathogen avirulence gene product (AVR), the R
protein is activated and triggers a host defense response. In
animals, the nucleotide-binding, oligomerization (NOD)-like
receptors (NLRs) are intracellular sensors of microbial patho-
gens and other signals (Petrilli et al., 2007). NLRs are essential
components of the animal immune and inflammation responses.
Most R proteins and NLRs belong to the NB-ARC family. Each
NB-ARC protein contains an N-terminal signaling domain (typi-
cally a CARD, a pyrin, or a coiled-coil (CC)/Toll and Interleukin
1 receptor (TIR) domain), a nucleotide-binding domain (a/b-fold
and HD1), a WHD, and a C-terminal protein-protein interaction
motif, usually WD40 or LRR repeats (Figure S4A).
The NB-ARC proteins exist in an inactive state prior to sig-
naling. CED-4 is maintained in an inactive state through CED-9
sequestration (Chen et al., 2000; James et al., 1997; Spector
et al., 1997; Wu et al., 1997; Yan et al., 2005). Structural analysis
revealed that Apaf-1 exists in an autoinhibited state through
binding to ADP and through extensive intradomain interactions
(Riedl et al., 2005). Both CED-4 and Apaf-1 must undergo an
activation process to form the death-inducing apoptosomes
(Figure 7). In the case of CED-4, the upstream protein EGL-1 is
needed to disrupt the CED-4-CED-9 interaction and to releaseCell 141, 446–457, April 30, 2010 ª2010 Elsevier Inc. 453
Figure 7. A Proposed Model for the Activation
and Deactivation of NB-ARC Proteins
An NB-ARC protein exists in an inactive state prior to
signaling. In response to signaling, the NB-ARC protein
oligomerizes to attain an active conformation. See main
text for details.CED-4 from the inhibitory complex (Conradt and Horvitz, 1998;
del Peso et al., 1998; Yan et al., 2004). The freed CED-4 dimer
further tetramerizes to form the CED-4 apoptosome. In the
case of Apaf-1, upstream cell death signaling causes the release
of cytochrome c from mitochondria, which binds to Apaf-1 and
allows Apaf-1 to exchange ADP/dADP for ATP/dATP (Bao
et al., 2007; Kim et al., 2005; Li et al., 1997). The binding of
ATP/dATP is the decisive event that leads to the formation of
the mammalian apoptosome.
How do other NB-ARC proteins maintain their inactive states?
Although a definitive answer is still at large, biochemical and
structural studies of CED-4 and Apaf-1 offer tantalizing clues.
We hypothesize that some NB-ARC proteins, such as the R
proteins RPS2 and RPM1, may emulate CED-4 and attain their
default, inactive states through interaction with other partner
proteins, such as RIN4 (Axtell and Staskawicz, 2003; Mackey
et al., 2002, 2003) (Figure 7). Other NB-ARC proteins, such as
the potato protein Rx (Moffett et al., 2002) and the tomato protein
I-2, are likely to be similar to Apaf-1 and maintain their dormancy
through intramolecular interactions (Figure 7).
Upon activation, the NB-ARC proteins are thought to form an
oligomeric complex. The shared sequence and domain homol-
ogy among the NB-ARC proteins suggests common principles
for assembly of the activated complex. In analogy to CED-4,
other NB-ARC proteins, such as Apaf-1 (Figure 4) and the
tobacco N disease resistance protein (Mestre and Baulcombe,
2006), are predicted to assemble into an activated complex via
domain organizations similar to those observed in the CED-4
apoptosome. Specifically, the WHD domain in each of these
NB-ARC proteins likely plays an essential role in oligomerization,
cushioning interdomain interactions and moderating ATP
binding and hydrolysis.
Implication for CED-3 Activation
Previous investigations showed that CED-4 facilitates the auto-
catalytic processing of the CED-3 zymogen (Seshagiri andMiller,
1997; Yan et al., 2005; Yang et al., 1998b). Our current studies
demonstrate that the processed CED-3 protease forms a stable
holoenzyme with the CED-4 apoptosome, within which CED-3
exhibits enhanced protease activity. This case is similar to that
of the caspase-9:Apaf-1 holoenzyme (Rodriguez and Lazebnik,
1999). Both CED-3 and caspase-9 exist as a monomer in their
zymogen forms, and both proteins continue to be monomeric454 Cell 141, 446–457, April 30, 2010 ª2010 Elsevier Inc.after their autocatalytic cleavages. In both
cases, the processed caspase physically asso-
ciates with the apoptosome to form an active
holoenzyme, within which the protease activity
of the caspase is markedly stimulated. These
similarities suggest that the principles derivedfrom this study may be relevant for understanding caspase-9
activation.
One unanticipated finding is that the molar ratio between
CED-4 and processed CED-3 is far from 1:1 in the CED-4:
CED-3 complex. Our observation is consistent with the study
by Bratton and colleagues (Malladi et al., 2009), where cas-
pase-9 was found to be present at a significantly lower molar
quantity compared to Apaf-1 in the caspase-9:Apaf-1 holoen-
zyme. Experimental evidence from our own laboratory supports
this finding (data not shown). Although the precise molar ratio
remains to be determined, the Apaf-1 apoptosome appears to
only recruit two to four, but not seven, molecules of caspase-9.
This scenario contrasts the prevailing model of caspase-9
activation (Boatright and Salvesen, 2003; Pop et al., 2006), which
predicted that the Apaf-1 apoptosome recruited seven mole-
cules of caspase-9 and the sheer proximity of these caspase-9
molecules drove their dimerization and subsequent activation.
The CARD of Apaf-1 was previously shown to be responsible
for the recruitment of caspase-9 through a CARD-CARD interac-
tion of 1:1 molar ratio (Li et al., 1997; Qin et al., 1999). Why can’t
the Apaf-1 apoptosome recruit seven molecules of caspase-9
then? One possibility is that binding of caspase-9 CARD to an
Apaf-1 molecule may create steric hindrance for neighboring
Apaf-1 molecules, preventing their interaction with additional
caspase-9 molecules. Another possibility is that association
of a caspase-9 molecule to the apoptosome may induce local
conformational rearrangements that impose a limit on recruit-
ment of additional caspase-9 molecules. A precise answer to
this question remains to be investigated.
The fact that only two molecules of CED-3 may be recruited
by the CED-4 apoptosome strongly suggests that these two
molecules of CED-3 may be activated through CED-4-assisted
homodimerization. The hutch of the CED-4 apoptosome seems
to be ideally designed to facilitate the docking and dimerization
of two CED-3 molecules—it may drastically increase the chance
for two CED-3 molecules to dimerize with each other and at the
same time decrease the likelihood of dissociation for the assem-
bled CED-3 homodimer. In this regard, the mechanism of CED-3
activation is best represented by the Induced Conformation
model (Chao et al., 2005; Shi, 2004). This mechanism is some-
what analogous to the protein folding chamber of GroEL—
unfolded substrate protein is trapped inside for efficient refolding
(Horwich et al., 2006). The volume of the hutch in the CED-4
apoptosome is 150,000 A˚3, compared to a cavity volume of
120,000 A˚3 in GroES-bound GroEL (Horwich et al., 2006).
The protease activity of caspase-9 is stimulated by 2–3 orders
of magnitude by the Apaf-1 holoenzyme (Rodriguez and Lazeb-
nik, 1999; Saleh et al., 1999; Zou et al., 1999). By contrast, the
CED-4 apoptosome can only stimulate the protease activity of
processed CED-3 by 5- to 10-fold. Why is there such a large
difference? This could be explained by differences in sub-
strate-induced dimerization. In the case of caspase-9, binding
to covalent inhibitors had little impact on its monomeric state
(Shiozaki et al., 2003). By contrast, incubation of the processed
CED-3 with DEVD-CHO shifted a portion of CED-3 from mono-
mer to dimer, as judged by gel filtration (Figure S6C). Thus, com-
pared to caspase-9, the processed CED-3 is muchmore likely to
undergo homodimerization in the presence of substrate, giving
rise to a higher basal level of protease activity. Consequently,
presence of the apoptosome, which serves to facilitate homodi-
merization of the caspase, had stronger impact on caspase-9
than on CED-3.
EXPERIMENTAL PROCEDURES
Protein Preparation and Assembly of the CED-4 Apoptosome
All constructs and point mutations were generated using a standard
PCR-based cloning strategy. The (CED-4)2:CED-9 complex and GST-EGL-1
were purified to homogeneity as described (Yan et al., 2004, 2005). The homo-
geneous CED-4 apoptosome was obtained as described (Yan et al., 2005).
Wild-type and mutant human Apaf-1DC (residues 1–591) proteins were
purified as described (Riedl et al., 2005). All clones of CED-3, with a C-terminal
His6 tag, were expressed or coexpressed in E. coli BL21(DE3). Soluble protein
was purified using Ni-NTA affinity resin, followed by gel filtration (Superdex-
200). An excess amount of the purified CED-3 protein was incubated with
CED-4 at 4C for 30 min. The stable CED-4:CED-3 complex was further
purified by gel filtration.
Structure Determination of the CED-4 Apoptosome
All crystals were grown at 18C. Fresh crystals were transferred into a cryo-
protectant buffer containing 20% glycerol and flash-frozen in liquid nitrogen
for data collection. Native datasets were collected from single crystals at the
SSRF BL17U beamline and processed with HKL2000 (Otwinowski and Minor,
1997). The crystals belong to the space group I422, with a = b = 181.6 A˚,
c = 203.2 A˚. The structure was determined by molecular replacement using
Phaser (McCoy et al., 2005). After cycles of rigid body and restraint refine-
ments by Refmac (Murshudov et al., 1999), the linker region (residues
91–108) of CED-4b was manually built in O (Jones et al., 1991). ATP and
Mg2+ were modeled in the same way as they are in the (CED-4)2:CED-9 com-
plex (Yan et al., 2005). Subsequent refinements of coordinates, individual B
factors, and TLS groups were done in phenix.refine (Adams et al., 2002).
NCS restraints were maintained throughout refinement.
Modeling Apaf-1 Heptamer
The atomic coordinates of individual domains of Apaf-1 (Protein Data Bank
code 1Z6T) were superimposed with the corresponding domains of CED-4a
in O (Jones et al., 1991). The new PDB files were combined to generate an
Apaf-1 monomer in extended conformation. The Apaf-1 heptamer model
was then generated by rotating the modified monomer along a central rotation
axis, at a step of 51.4, seven times successively with CCP4 program
PDBSET (Collaborative Computational Project, 1994).
Mutagenesis Analysis of the Apaf-1 Miniapoptosome
For assembly of the Apaf-1 miniapoptosome, wild-type and mutant Apaf-1
(residues 1–591) were incubated with 1 mM dATP at 4C for 4 hr as described
(Bao et al., 2007).Structure Determination of the CED-4:CED-3 Complex
The crystals belong to space group I422, with a = b = 181.33 A˚, c = 202.88 A˚,
a = b = g = 90. Data were collected at the Spring-8 beamline BL41XU and
processed with the HKL2000 package (Otwinowski and Minor, 1997). The
atomic coordinates of CED-4 from the PDB entry 2A5Y (Yan et al., 2005)
were used for molecular replacement with the program PHASER (McCoy
et al., 2005). Manual model building was done using the program COOT
(Emsley and Cowtan, 2004). The model was refined in the program PHENIX
(Adams et al., 2002).
Electron Microscopy
The frozen-hydrated samples were imaged at a JEOL 2010F electron micro-
scope operating at 200 kV. Images were recorded on Kodak SO-163 negative
films, and the films were developed in the full-strength Kodak D-19 developer.
The single particle images, 27704 and 21549 for CED-4 and CED-4-CED-3,
respectively, were classified and averaged in EMAN (Ludtke et al., 1999).
In Vitro Translation of CED-3
The experiments were performed as described (Yan et al., 2005).
Capillary Electrophoresis
The denatured proteins were separated by capillary electrophoresis and de-
tected at 280 nm by a UV spectrophotometer. A 31.2 cm 3 75 mm, uncoated
fused-silica capillary was used and the separation voltage was applied at 3 kV.
Isothermal Titration Calorimetry
The unprocessed CED-3 or the two-chain CED-3 was titrated by CED-4. All
experiments were performed with a VP-ITC microcalorimeter (MicroCal). The
data were fitted using the software Origin 7.0 (MicroCal).
Caspase Assay for CED-3
The fluorogenic peptide Ac-DEVD-AMCwas used as the substrate tomeasure
the protease activity of CED-3 variants.
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